bisbenzimidazole has been researched along with Hemolysis in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thamban Chandrika, N | 1 |
Shrestha, SK | 1 |
Ranjan, N | 1 |
Sharma, A | 1 |
Arya, DP | 1 |
Garneau-Tsodikova, S | 1 |
van Vianen, PH | 1 |
van Engen, A | 1 |
Thaithong, S | 1 |
van der Keur, M | 1 |
Tanke, HJ | 1 |
van der Kaay, HJ | 1 |
Mons, B | 1 |
Janse, CJ | 1 |
2 other studies available for bisbenzimidazole and Hemolysis
Article | Year |
---|---|
New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents.
Topics: Antifungal Agents; Biofilms; Bisbenzimidazole; Candida albicans; Dose-Response Relationship, Drug; F | 2018 |
Flow cytometric screening of blood samples for malaria parasites.
Topics: Animals; Bisbenzimidazole; Cell Count; Cell Separation; DNA; Flow Cytometry; Formaldehyde; Hemolysis | 1993 |